HTT and Huntington disease: This system was further validated in a transgenic Huntington’s disease mouse model bearing mutations in the HTT gene; a substantial decrease in HTT mRNA and protein was observed in the right hemisphere of the brain following a localized viral injection compared with the contralateral, untreated hemisphere (67).